ESR1 and breast cancer: Triple-negative breast cancer (TNBC), which accounts for approximately 15–20% of all breast cancers, is characterized by a lack of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) [2].